一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Accounts of Chemical Research >>article
Accounts of Chemical Research

Accounts of Chemical Research

IF: 16.4
Download PDF

Intravitreal fluocinolone acetonide implant for chronic postoperative cystoid macular edema - two years results.

Published:4 September 2022 DOI: 10.1177/11206721221124688 PMID: 36062617
Argyrios Chronopoulos,?Panagiotis Chronopoulos,?L O Hattenbach,?Agharza Ashurov,?James S Schutz,?Norbert Pfeiffer,?Christina Korb

Abstract

Purpose: We report visual and anatomical outcomes of chronic postoperative macular edema treated with a fluocinolone acetonide intravitreal implant.

Method: Retrospective study of chronic, post-surgical CME treated with a fluocinolone acetonide intravitreal implant. Best registered visual acuity (BRVA), central retinal thickness (CRT), and Goldmann tonometry intraocular pressure (IOP) were assessed over 24 months. The need for IOP lowering treatment, top-up therapy during follow-up, and complications were also assessed.

Results: We analyzed 16 consecutive eyes of 16 patients with chronic, post-surgical CME treated with fluocinolone acetonide intravitreal implant. Surgical indications included cataract surgery, vitrectomy plus membrane peeling and combined phaco-vitrectomy. Baseline mean BRVA of 0.8?±?0.65 logMAR improved to 0.60?±?0.4 logMAR (p?=?0.02) at 12 months and to 0.7?±?0.5 logMAR (p?=?0.32) at 24 months. At month 12, BRVA improved in 11 eyes, stabilized in 4 eyes, and decreased in 1 eye. At month 24, VA remained improved in 5 eyes, remained stabilized in 5 eyes, and decreased in 1 eye. Mean CRT decreased from 524?±?132?μm at baseline to 389?μm at month 3, 347?μm at month 6, 355?±?106?μm (p?=?0.0003) at month 12, and 313?±?83?μm (p?=?0.0001) at month 24. At 12 months, CRT improved in 13 eyes and remained unchanged in 2 eyes. At 24 months, CRT improved further in 8 eyes, and stabilized in 3 eyes. Increased IOP (≥21?mmHg) was observed only in 4 eyes, all successfully managed with topical medication. No further side effects were observed in any patient.

Conclusion: Visual and anatomic improvements were achieved by a single fluocinolone acetonide implant with few side effects up to 24 months in CME eyes with a long and heavy prior treatment history.

Substances (1)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Fluocinolone Acetonide 67-73-2 C24H30F2O6 507 suppliers $28.00-$1674.75

Similar articles

IF:4.3

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.

ACS Applied Electronic Materials Noemi Lois, Evie Gardner,etc Published: 14 July 2020
马边| 城市| 鹤壁市| 宁都县| 江川县| 西乌| 巴彦淖尔市| 彩票| 呈贡县| 老河口市| 湘阴县| 舒城县| 缙云县| 屏南县| 三河市| 巴中市| 天镇县| 眉山市| 桦甸市| 荔波县| 汾阳市| 武胜县| 乌什县| 瓦房店市| 安阳县| 江永县| 斗六市| 来安县| 南岸区| 石屏县| 西畴县| 乐陵市| 金华市| 七台河市| 金溪县| 博爱县| 贵溪市| 杭州市| 沧州市| 松桃| 泰和县|